1
|
Beard M, Huang E, Hashmi S, Sharmeen S. Silent Inflammation: A Case of Blurry Vision Raising Diagnostic Challenges in an Elderly Patient. Cureus 2024; 16:e74822. [PMID: 39737319 PMCID: PMC11684141 DOI: 10.7759/cureus.74822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2024] [Indexed: 01/01/2025] Open
Abstract
Giant cell arteritis (GCA) is a large vessel vasculitis with cranial and extracranial vessel involvement. Clinicians suspect GCA when a patient exhibits symptoms or exam findings of temporal headache with sudden vision loss, jaw or tongue claudication, scalp tenderness, abnormal temporal artery exam, and diagnostic findings, including elevated inflammatory markers. We present a case, which highlights that, despite established diagnostic measures, challenges persist. The unexpected presentation serves as a valuable reminder of the condition's diverse manifestations.
Collapse
Affiliation(s)
- Meghan Beard
- Department of Medicine, Division of Rheumatology, Allergy and Immunology, Stony Brook University Hospital, Stony Brook, USA
| | - Emily Huang
- Department of Pathology, Stony Brook University Hospital, Stony Brook, USA
| | - Shariq Hashmi
- Department of Ophthalmology, Stony Brook University Hospital, Stony Brook, USA
| | - Saika Sharmeen
- Department of Medicine, Division of Rheumatology, Allergy and Immunology, Stony Brook University Hospital, Stony Brook, USA
| |
Collapse
|
2
|
Desbois AC, Régnier P, Quiniou V, Lejoncour A, Maciejewski-Duval A, Comarmond C, Vallet H, Rosenzwag M, Darrasse-Jèze G, Derian N, Pouchot J, Samson M, Bienvenu B, Fouret P, Koskas F, Garrido M, Sène D, Bruneval P, Cacoub P, Klatzmann D, Saadoun D. Specific Follicular Helper T Cell Signature in Takayasu Arteritis. Arthritis Rheumatol 2021; 73:1233-1243. [PMID: 33538119 DOI: 10.1002/art.41672] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Revised: 12/09/2020] [Accepted: 01/28/2021] [Indexed: 01/21/2023]
Abstract
OBJECTIVE Our aim was to compare transcriptome and phenotype profiles of CD4+ T cells and CD19+ B cells in patients with Takayasu arteritis (TAK), patients with giant cell arteritis (GCA), and healthy donors. METHODS Gene expression analyses, flow cytometry immunophenotyping, T cell receptor (TCR) gene sequencing, and functional assessments of cells from peripheral blood and arterial lesions from TAK patients, GCA patients, and healthy donors were performed. RESULTS Among the most significantly dysregulated genes in CD4+ T cells of TAK patients compared to GCA patients (n = 720 genes) and in CD4+ T cells of TAK patients compared to healthy donors (n = 1,447 genes), we identified a follicular helper T (Tfh) cell signature, which included CXCR5, CCR6, and CCL20 genes, that was transcriptionally up-regulated in TAK patients. Phenotypically, there was an increase in CD4+CXCR5+CCR6+CXCR3- Tfh17 cells in TAK patients that was associated with a significant enrichment of CD19+ B cell activation. Functionally, Tfh cells helped B cells to proliferate, differentiate into memory cells, and secrete IgG antibodies. Maturation of B cells was inhibited by JAK inhibitors. Locally, in areas of arterial inflammation, we found a higher proportion of tertiary lymphoid structures comprised CD4+, CXCR5+, programmed death 1+, and CD20+ cells in TAK patients compared to GCA patients. CD4+CXCR5+ T cells in the aortas of TAK patients had an oligoclonal α/β TCR repertoire. CONCLUSION We established the presence of a specific Tfh cell signature in both circulating and aorta-infiltrating CD4+ T cells from TAK patients. The cooperation of Tfh cells and B cells might be critical in the occurrence of vascular inflammation in patients with TAK.
Collapse
Affiliation(s)
- A C Desbois
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - P Régnier
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - V Quiniou
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - A Lejoncour
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - A Maciejewski-Duval
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - C Comarmond
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - H Vallet
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - M Rosenzwag
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - G Darrasse-Jèze
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - N Derian
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - J Pouchot
- Hôpital Européen Georges-Pompidou, AP-HP, Université Paris Descartes, Paris, France
| | - M Samson
- Centre Hospitalier Universitaire Dijon Bourgogne, Université Bourgogne-Franche Comté, INSERM EFS Bourgogne-Franche Comté UMR1098, Dijon, France
| | - B Bienvenu
- Centre Hospitalier Universitaire Caen, Caen, France
| | - P Fouret
- Groupe Hospitalier Pitié-Salpétrière, Paris, France
| | - F Koskas
- Groupe Hospitalier Pitié-Salpétrière, Paris, France
| | - M Garrido
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - D Sène
- Hôpital Lariboisière, Paris, France
| | - P Bruneval
- Hôpital Européen Georges Pompidou, AP-HP, Paris, France
| | - P Cacoub
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - D Klatzmann
- Sorbonne Université, INSERM UMR 959, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - D Saadoun
- Sorbonne Université, Centre National de Références Maladies Autoimmunes et Systémiques Rares et Maladies Autoinflammatoires Rares, INSERM UMR 959, Groupe Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| |
Collapse
|
3
|
Espitia O, Blonz G, Urbanski G, Landron C, Connault J, Lavigne C, Roblot P, Maillot F, Audemard-Verger A, Artifoni M, Durant C, Guyomarch B, Hamidou M, Magnant J, Agard C. Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis Res Ther 2021; 23:14. [PMID: 33413605 PMCID: PMC7792092 DOI: 10.1186/s13075-020-02396-5] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2020] [Accepted: 12/13/2020] [Indexed: 12/12/2022] Open
Abstract
Background Giant cell arteritis (GCA) is frequently associated with aortic involvement that is likely to cause life-threatening structural complications (aneurysm, dissection). Few studies have investigated the occurrence of these complications, and no predictive factor has been identified so far. The aim of this study was to investigate factors associated with the risk of aortic complications in a cohort of GCA aortitis. Methods Data of all patients managed with aortitis (CT or 18 FDG PET) at the diagnosis of GCA in five hospitals from May 1998 and April 2019 were retrospectively collected. Clinical features were compared according to the presence of aortitis symptoms. The predictive factors of occurrence or aggravation of aortic structural abnormalities were investigated. Results One hundred and seventy-one patients with GCA aortitis were included; 55 patients (32%) had symptoms of aortitis (dorsal/lumbar/abdominal pain, aortic insufficiency) at diagnosis. The median follow-up was 38 months. Aortic complications occurred after a median time of 32 months. There were 19 new aortic aneurysms or complications of aneurysm and 5 dissections. Survival without aortic complication was significantly different between the symptomatic and non-symptomatic groups (Log rank, p = 0.0003). In multivariate analysis the presence of aortitis symptoms at diagnosis (HR 6.64 [1.95, 22.6] p = 0.002) and GCA relapse (HR 3.62 [1.2, 10.9] p = 0.02) were factors associated with the occurrence of aortic complications. Conclusion In this study, the presence of aortitis symptoms at the diagnosis of GCA aortitis and GCA relapse were independent predictive factors of occurrence of aortic complications during follow-up.
Collapse
Affiliation(s)
- Olivier Espitia
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France.
| | - Gauthier Blonz
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | | | - Cédric Landron
- Department of Internal Medicine, CHU Poitiers, Poitiers, France
| | - Jérôme Connault
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | | | - Pascal Roblot
- Department of Internal Medicine, CHU Poitiers, Poitiers, France
| | | | | | - Mathieu Artifoni
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | - Cécile Durant
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | - Béatrice Guyomarch
- Research Department, Methodology and Biostatistics Platform, CHU Nantes, Nantes, France
| | - Mohamed Hamidou
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | - Julie Magnant
- Department of Internal Medicine, CHRU Tours, Tours, France
| | - Christian Agard
- Department of Internal Medicine, CHU Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France
| | | |
Collapse
|